Adipotide (5mg)

Research use only

Adipotide, also known as Prohibition-targeting peptide 1 (TP01) or FTPP, is a peptidomimetic designed to bind to receptor proteins ANXA2 and prohibition, which are selectively found on the blood vessels supplying white adipose tissue. This binding induces apoptosis of those vessels, resulting in targeted adipocyte loss. Early preclinical studies in rodent and nonhuman primate obesity models demonstrated rapid fat reduction, improved insulin sensitivity, and reduced BMI.

Adipotide, also known as Prohibition-targeting peptide 1 (TP01) or FTPP, is a peptidomimetic designed to bind to receptor proteins ANXA2 and prohibition, which are selectively found on the blood vessels supplying white adipose tissue. This binding induces apoptosis of those vessels, resulting in targeted adipocyte loss. Early preclinical studies in rodent and nonhuman primate obesity models demonstrated rapid fat reduction, improved insulin sensitivity, and reduced BMI.

Lyophilized formulation supplied in vials (5 mg). Store at room temperature if protected from light for short-term storage; for long-term storage, store at –20 °C with desiccant. Once reconstituted (e.g., in sterile distilled water or a buffered solution with 0.1% BSA), aliquot and store at –20 °C, avoiding multiple freeze–thaw cycles.

Lyophilized formulation supplied in vials (5 mg). Store at room temperature if protected from light for short-term storage; for long-term storage, store at –20 °C with desiccant. Once reconstituted (e.g., in sterile distilled water or a buffered solution with 0.1% BSA), aliquot and store at –20 °C, avoiding multiple freeze–thaw cycles.

For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.

Frequently bought together: AOD-9604 (5 mg), BPC-157 (5 mg, 10 mg), CJC-1295 no DAC (5mg)